Jian Kong

1.3k total citations
37 papers, 1.0k citations indexed

About

Jian Kong is a scholar working on Molecular Biology, Hepatology and Cancer Research. According to data from OpenAlex, Jian Kong has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Hepatology and 14 papers in Cancer Research. Recurrent topics in Jian Kong's work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Angiogenesis and VEGF in Cancer (6 papers). Jian Kong is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Angiogenesis and VEGF in Cancer (6 papers). Jian Kong collaborates with scholars based in China, United States and Romania. Jian Kong's co-authors include Lemin Zheng, Wenbing Sun, Shan Ke, Shuying Dong, Jun Gao, Xuemei Ding, Jinge Kong, Shaohong Wang, Bing Pan and Hui‐Chuan Sun and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Jian Kong

35 papers receiving 1000 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian Kong China 19 433 345 324 175 174 37 1.0k
Simon Weonsang Ro South Korea 19 670 1.5× 257 0.7× 276 0.9× 224 1.3× 176 1.0× 41 1.1k
Eva Crosas‐Molist Spain 16 625 1.4× 224 0.6× 217 0.7× 293 1.7× 183 1.1× 22 1.2k
Chris K. Sun Hong Kong 23 791 1.8× 316 0.9× 333 1.0× 299 1.7× 208 1.2× 25 1.4k
Mitsuhiko Abe Japan 16 425 1.0× 324 0.9× 143 0.4× 189 1.1× 170 1.0× 30 905
Chiara Busletta Italy 9 356 0.8× 283 0.8× 297 0.9× 226 1.3× 299 1.7× 15 940
Tomohiko Sakabe Japan 17 475 1.1× 197 0.6× 171 0.5× 248 1.4× 162 0.9× 43 991
Dali Zhao China 12 431 1.0× 293 0.8× 157 0.5× 143 0.8× 153 0.9× 18 762
De-Ning Ma China 17 558 1.3× 416 1.2× 103 0.3× 216 1.2× 83 0.5× 38 1.1k
Peng Xiu China 17 385 0.9× 280 0.8× 135 0.4× 210 1.2× 117 0.7× 30 868

Countries citing papers authored by Jian Kong

Since Specialization
Citations

This map shows the geographic impact of Jian Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Kong more than expected).

Fields of papers citing papers by Jian Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Kong. The network helps show where Jian Kong may publish in the future.

Co-authorship network of co-authors of Jian Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Jian Kong. A scholar is included among the top collaborators of Jian Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian Kong. Jian Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kong, Jian, Shan Ke, Tao Yin, et al.. (2023). Thermal ablation of hepatic hemangioma: A multi-center experience with long-term outcomes. European Journal of Radiology. 164. 110842–110842. 4 indexed citations
3.
Kong, Jian, et al.. (2023). Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies. Cancer Biology and Medicine. 20(1). 25–43. 81 indexed citations
4.
Dong, Shuying, et al.. (2022). Arsenic trioxide inhibits angiogenesis of hepatocellular carcinoma after insufficient radiofrequency ablation via blocking paracrine angiopoietin-1 and angiopoietin-2. International Journal of Hyperthermia. 39(1). 888–896. 15 indexed citations
5.
Li, Zhuxin, Shuying Dong, Jun Gao, et al.. (2022). Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research. Frontiers in Oncology. 12. 1032746–1032746. 13 indexed citations
7.
Yin, Tao, et al.. (2019). miR-152-3p Modulates hepatic carcinogenesis by targeting cyclin-dependent kinase 8. Pathology - Research and Practice. 215(6). 152406–152406. 28 indexed citations
8.
Ding, Xuemei, Jian Kong, Shuying Dong, et al.. (2018). ATPase inhibitory factor 1 inhibition improves the antitumor of YC‑1 against hepatocellular carcinoma. Oncology Letters. 16(4). 5230–5236. 5 indexed citations
9.
Zhang, Qingyun, et al.. (2017). Metformin exhibits the anti-proliferation and anti-invasion effects in hepatocellular carcinoma cells after insufficient radiofrequency ablation. Cancer Cell International. 17(1). 48–48. 19 indexed citations
10.
Wang, Shaohong, Jun Gao, Mengmeng Yang, et al.. (2017). Intratumoral coagulation by radiofrequency ablation facilitated the laparoscopic resection of giant hepatic hemangioma: a surgical technique report of two cases. Oncotarget. 8(31). 52006–52011. 10 indexed citations
11.
Gao, Jun, Yiming Zhou, Jian Kong, et al.. (2016). Early Laparoscopic Radiofrequency Ablation for Spontaneous Rupture of Hepatocellular Carcinoma. Journal of Laparoendoscopic & Advanced Surgical Techniques. 26(7). 560–566. 8 indexed citations
12.
Liu, Yuanyuan, Chenghe Fan, Pu Lv, et al.. (2016). Phloretin induces cell cycle arrest and apoptosis of human glioblastoma cells through the generation of reactive oxygen species. Journal of Neuro-Oncology. 128(2). 217–223. 43 indexed citations
14.
Gao, Jun, Jian Kong, Xuemei Ding, et al.. (2015). Laparoscopicvscomputerized tomography-guided radiofrequency ablation for large hepatic hemangiomas abutting the diaphragm. World Journal of Gastroenterology. 21(19). 5941–5949. 18 indexed citations
15.
Dong, Shuying, Jian Kong, Jinge Kong, et al.. (2015). Low Concentration of Caffeine Inhibits the Progression of the Hepatocellular Carcinoma <i>via Akt</i> Signaling Pathway. Anti-Cancer Agents in Medicinal Chemistry. 15(4). 484–492. 21 indexed citations
16.
Dong, Shuying, Jian Kong, Jinge Kong, et al.. (2015). Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation. BMC Cancer. 15(1). 939–939. 36 indexed citations
17.
Kong, Jian, Qiangbo Zhang, Shuying Dong, et al.. (2014). YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma. Molecular Cancer. 13(1). 7–7. 38 indexed citations
18.
Dong, Shuying, Jian Kong, Jinge Kong, et al.. (2013). Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways. Journal of Translational Medicine. 11(1). 273–273. 69 indexed citations
19.
Gu, Fang, Xiuli Li, Jian Kong, et al.. (2013). VEGF111b, a new member of VEGFxxxb isoforms and induced by mitomycin C, inhibits angiogenesis. Biochemical and Biophysical Research Communications. 441(1). 18–24. 14 indexed citations
20.
Pan, Bing, Hui Ren, Yubin He, et al.. (2012). HDL of Patients with Type 2 Diabetes Mellitus Elevates the Capability of Promoting Breast Cancer Metastasis. Clinical Cancer Research. 18(5). 1246–1256. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026